Form 4: Procter & Gamble Director Terry J. Lundgren Reports Acquisition of Common Stock
SEC Form 4 Filing
Director Terry J. Lundgren reports acquiring 181 shares of Procter & Gamble common stock and holding 42,400.5418 shares directly and 530 shares indirectly through a spouse.
Summary
- On March 11, 2025, Terry J. Lundgren, a director of Procter & Gamble, acquired 181 shares of common stock.
- The acquisition was made at a price of $0, likely indicating a grant of restricted stock units.
- Following the transaction, Lundgren directly owns 42,400.5418 shares of Procter & Gamble common stock.
- Lundgren also indirectly owns 530 shares through his spouse.
- The reported transaction includes dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine disclosure of stock acquisition by a director. The acquisition itself can be seen as mildly positive, but the filing is primarily informational.
Positives
- The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment due to the director's increased investment in the company.
Key Dates
| Date | Description |
|---|---|
| 03/11/2025 | Date of transaction: Acquisition of common stock. |
| 03/12/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.